Abstract

In this study, we prepared human bone morphogenetic protein-2 (hBMP-2)/human growth and differentiation factor-5 (hGDF-5)-coated titanium (Ti) disc and screw types for controlled release of the growth factors (GFs). The two growth factors were coated onto Ti with a smooth surface using their specific interaction with heparin, because they have heparin binding sites in their molecular structures. Efficacy of the two growth factor-coated Ti for enhancement of bone formation and osseointegration was compared to pristine Ti, and hBMP-2- and hGDF-5-coated Ti in vivo. The surface chemical composition, surface morphology, and wettability characteristics of the metal samples were determined by X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), and contact angle measurement, respectively. The initial burst of hBMP-2, hGDF-5, and their combination, occurred within one day of the release study, resulting in 12.5%, 4.5%, and 13.5%/3.2%, and then there was a sustained, even release of these two growth factors from the coated metal for 30 days. In vitro tests revealed that MC3T3-E1 cells cultured on the two growth factor-coated Ti had a higher proliferation rate and a higher activity for alkaline phosphatase (ALP), which led to a larger amount of calcium deposition and larger expressions of type I collagen (COL 1), ALP, and osteocalcin (OCN) mRNAs. In vivo animal tests using ten white New Zealand rabbits showed that the two growth factor-coated Ti enhanced bone formation and osseointegration at the interface between the implants and host bone. In addition, histological evaluation showed that bone remodeling, including bone formation by osteoblasts and bone resorption by osteoclasts, actively occurred between the two growth factor-coated Ti and host bone. Consequently, it is suggested that Ti surface modification with the combination of hBMP-2 and hGDF-5 for the two growth factor-coated Ti implants can improve the clinical properties of implants for orthopedic and dental applications.

Highlights

  • Titanium (Ti) and its alloys are widely used as implants in dental and orthopedic fields [1]

  • The surface modifications were further explained by the examination of atomic Ti2p, C1s and O1s percentages. human bone morphogenetic protein-2 (hBMP-2)/Ti, human growth and differentiation factor-5 (hGDF-5)/Ti, and hBMP-2/hGDF-5/Ti had lower percentages of Ti2p (1.01%, 1.95% and 1.49%) than pristine Ti (12.72%)

  • Our results indicated that hBMP-2, hGDF-5 and the double layer-coated Ti implants with heparin released them in a sustained manner (Figure 4)

Read more

Summary

Introduction

Titanium (Ti) and its alloys are widely used as implants in dental and orthopedic fields [1]. Various surface modifications, such as laser irradiation, acid-etching, and incorporation of ceramics, have been proposed for the achievement of such purposes [2,3,4]. The various surface modifications have insufficient for achieving these aims. Surface modifications with the bone morphogenetic protein (BMP) family of growth factors are being introduced for satisfactory initial osseointegration [3,5,6]. Bone morphogenetic protein-2 (BMP-2) and growth and differentiation factor-5 (GDF-5) have received significant attention from researchers due to their abilities for enhancement of osseointegration and bone formation in vivo [5,6]. GDF-5 is less known as a growth factor for the enhancement of bone formation, as compared to BMP-2. Some studies proved that GDF-5 plays a leading role in regenerating the bone on damaged periodontal ligament tissue [7,8,9]

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call